At Stanford’s Drug Discovery Symposium, biotech executives spoke openly about how the scientific ecosystem is now in jeopardy ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...

On this week’s episode of the Readout LOUD, we review President Trump’s first 100 days, the return of biotech M&A, strong ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

President Donald Trump said on Wednesday that there will be a tariff "wall" for pharmaceutical companies operating in the ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The testing center that oversees food safety says it "is no longer able to provide laboratory support for proficiency testing ...

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

President Trump’s first 100 days has roiled health and science as part of the administration’s plan to reshape the federal ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...